![Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients - Curium Pharma Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients - Curium Pharma](https://www.curiumpharma.com/wp-content/uploads/2018/05/Curium-wall.jpg)
Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients - Curium Pharma
![Ultra-Technekow™ V4 (Technetium Tc 99m Generator) Rx only For the Production of Sodium Pertechnetate Tc 99m Injection Ultra-Technekow™ V4 (Technetium Tc 99m Generator) Rx only For the Production of Sodium Pertechnetate Tc 99m Injection](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=ultra-technekow-v4-69945-1.jpg&id=641873)
Ultra-Technekow™ V4 (Technetium Tc 99m Generator) Rx only For the Production of Sodium Pertechnetate Tc 99m Injection
![PSMA-GCK01: A Generator-Based 99mTc/188Re Theranostic Ligand for the Prostate-Specific Membrane Antigen | Journal of Nuclear Medicine PSMA-GCK01: A Generator-Based 99mTc/188Re Theranostic Ligand for the Prostate-Specific Membrane Antigen | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/64/7/1069/F1.large.jpg)
PSMA-GCK01: A Generator-Based 99mTc/188Re Theranostic Ligand for the Prostate-Specific Membrane Antigen | Journal of Nuclear Medicine
![Chapter 4: Radionuclide Production | Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine, 4th Edition | PharmacyLibrary Chapter 4: Radionuclide Production | Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine, 4th Edition | PharmacyLibrary](https://pharmacylibrary.com/cms/10.21019/9781582122830.ch4/asset/images/medium/f15298-004-004-4c.gif)